# Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

> **NCT05208931** · — · COMPLETED · sponsor: **The S.N. Fyodorov Eye Microsurgery State Institution** · enrollment: 300 (actual)

## Conditions studied

- Neovascular Age-related Macular Degeneration

## Interventions

- **PROCEDURE:** Anti-vascular endothelial growth factor therapy

## Key facts

- **NCT ID:** NCT05208931
- **Lead sponsor:** The S.N. Fyodorov Eye Microsurgery State Institution
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05208931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05208931, "Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05208931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*